Stay updated on NC410 Plus Pembrolizumab Clinical Trial
Sign up to get notified when there's something new on the NC410 Plus Pembrolizumab Clinical Trial page.

Latest updates to the NC410 Plus Pembrolizumab Clinical Trial page
- Check6 days agoChange DetectedThe footer’s ClinicalTrials.gov site revision changed from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check13 days agoChange DetectedThe footer revision identifier updates from v3.7.0 to v3.7.1, with no change to the displayed study record.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedThe revision history now shows a new entry for v3.7.0, replacing the previous v3.6.6. This reflects a backend or UI update to the page's revision-tracking rather than changes to the study data.SummaryDifference0.1%

- Check55 days agoChange DetectedThe history now shows the latest revision as v3.6.6, replacing the previous v3.6.5. This is a metadata update with no impact on the study information.SummaryDifference0.1%

- Check69 days agoChange DetectedVersion updates show termination after Phase 1b and the posting of results for the NC410 plus Pembrolizumab trial. The history also adds updates to the study status and includes Outcome Measures in the results section.SummaryDifference0.9%

- Check76 days agoChange DetectedThe study record's change history adds a new revision entry v3.6.5; the previous revision v3.6.4 is listed under deletions, signaling an update to the version history.SummaryDifference0.1%

Stay in the know with updates to NC410 Plus Pembrolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the NC410 Plus Pembrolizumab Clinical Trial page.